Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This Bitcoin-focused microcap is building a treasury strategy centered on accumulating BTC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News BioCardia Inc BCDA

Healthcare Biotechnology
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company’s lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BCDA)

BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure

GlobeNewswire April 2, 2026

BioCardia Reports 2025 Business Highlights and Financial Results

GlobeNewswire March 24, 2026

BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

GlobeNewswire March 19, 2026

BioCardia Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA

GlobeNewswire March 17, 2026

BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT)

GlobeNewswire March 3, 2026

BioCardia Files Pre-Submission for FDA Approval of Helix(TM) Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart

GlobeNewswire February 10, 2026

BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT)

GlobeNewswire February 3, 2026

BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA

GlobeNewswire December 16, 2025

BioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno

GlobeNewswire December 3, 2025
View More News ››

Opinion & Analysis (NDAQ:BCDA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:BCDA)

Sell buddy sell.Wow.

This company did a below the market price cheap financing,so that they pulled the rug out on the existing shareholders today anyway and...
coolfooldumbguy - September 18, 2025

BUY buddy BUY

Because it's going up big-time and it's FOMO time for you fellas out there
coolfooldumbguy - August 4, 2025

BioCardia, Inc. (NASDAQ:BCDA): Promising Autologous and Allo

http://beyondspx.com/2024/08/02/biocardia-inc-nasdaqbcda-promising-autologous-and-allogeneic-cell-therapies-for-cardiovascular-diseases/
MikeTester - August 3, 2024

BUY BUY BUY BUY BUY

Time to load up
Nibinator - July 20, 2024

BCDA....The P & D that could ; )

Early a.m runner on FDA NR ...funny how this has changed since the last NR in September cast a black cloud  Now FDA approval.....no...
Iseneschal - November 14, 2023

BCDA .... Meh ....just a P & D

CHeers !
Iseneschal - April 12, 2022
View more Bullboard ››

Interactive Capital Partners Corporation

Interactive Capital Partners Corporation

View More »

Podcasts